GlassScriptPhysician profile
Hong M Le
NPI 1992850994
$2,417.73
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,002 · 2020: $416.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $454.02 | 2019-2020 | |
| Novo Nordisk INC | $357.52 | 2019-2020 | |
| Pfizer INC. | $312.73 | 2019-2020 | |
| Lilly USA, LLC | $190.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $160.76 | 2019-2020 | |
| Allergan, INC. | $158.67 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $140.36 | 2019-2020 | |
| Amgen INC. | $91.26 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.51 | 2019-2020 | |
| Abbvie INC. | $69.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $54.35 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $51.03 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.82 | 2019-2020 | |
| Celgene Corporation | $41.83 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $33.77 | 2019 | |
| Ethicon US, LLC | $30.90 | 2019 | |
| Glaxosmithkline, LLC. | $30.71 | 2020 | |
| Metuchen Pharmaceuticals | $18.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.25 | 2019 | |
| Circassia INC. | $13.71 | 2019 | |
| Ibsa Pharma INC. | $12.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hong Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.